ABL
Coralie Bernard is a highly experienced Technicienne specializing in quality control in various laboratories. Coralie has worked at ABL Europe, Sanofi Pasteur, and EPISKIN SA, focusing on tasks such as quantification of viral titers, monitoring pharmaceutical waters, microbiological environmental controls, GMP raw materials tracking, and more. With a background in biology, biochemistry, and biotechnology, Coralie has a strong foundation in laboratory techniques and research methodologies.
ABL
From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.